With 13 offices in China, Guantao Law Firm provides legal services across all practice areas. The firm is ranked ‘Highly recommended’ in restructuring and insolvency. Its team advises non-bank financial institutions on dissolution liquidation, insolvency liquidation and insolvency reorganisation. Managing partner Liguo Cui has expertise in transactional law with a focus on aviation, financial services, manufacturing, pharmaceuticals and healthcare. Jia Song and Shiming Xiang joined the firm as partners in 2021, both specialised in capital markets.
Work highlights
Represented China Huarong Asset Management (Beijing Branch) in a financial non-performing claims recovery dispute against Wuxi Suyuan Real Estate and Chongqing Sunshine 100 Real Estate Development.
Successfully represented ZF Marine Krimpen in a sales contract dispute against CRRC Hange Marine & Offshore Engineering.
Key clients
China Securities, Concord Investment (China), Shanghai KaiLong Investment Management, Xiamen Weiken Commercial Factoring
Work highlights
Acting for Xihe Holdings (Singapore) on its bankruptcy and reorganisation case, to handle the case of arrest of Ocean Stellar due to its inability to pay the repair fee after its repair and maintenance in China.
Acted for Beijing Urban Construction and Property Management on its compulsory liquidation.
Key clients
Everbright Prestige Capital Asset Management
Work highlights
Acted for CK Asset Holdings on its purchase of shares of Eagle Frame, Mondrem Corporation, Moonstone Global Investment, and Gerbera Property Investments from Li Ka Shing Foundation.
Acted for China Power Engineering Consulting on the Jixi Zhonglu High Altitude Wind Power Generation Station acquisition project.
Advised Beijing Huaxiang Baipenyao Property Development on its takeover of Jindi Xuhui Jiangshan Fenghua S1 commercial/office block and relevant proprietary parking space.
Key clients
China Energy Engineering Corporation, Guangdong Land Holdings, Huayi Tencent Entertainment Company
Work highlights
Represented China Insurance Investment (Beijing) in raising a corporate-system fund and investing in the newly issued shares of China Huarong Asset Management.
Acted for Beijing Health Guard Biotechnology on its financing.
Advised Qingdao NovelBeam Technology on its issuance of A shares on the sci-tech innovation board of the Shanghai Stock Exchange.
Key clients
Allgens Medical Technology, Beijing Jingwei Hirain Technologies, KEDE Numerical Control
